Tick borne illness-Lyme disease

Area of Science:

• Infectious Diseases
• Epidemiology
• Tick-borne Illnesses

Background:

• Lyme disease is the most prevalent tick-borne illness in the United States, caused by the spirochete Borrelia burgdorferi.
• Transmission occurs via Ixodes ticks, with major US incidence in the Northeast and upper Midwest, and also reported in Europe, China, and Japan.
• The white-footed mouse serves as the primary reservoir for B. burgdorferi, while deer host adult ticks.

Purpose of the Study:

• To summarize the epidemiology, clinical presentation, diagnosis, and treatment of Lyme disease.
• To address the controversy surrounding 'Chronic Lyme Disease' and unproven therapies.
• To highlight co-infections transmitted by the same tick vectors.

Main Methods:

• Clinical evaluation forms the basis of diagnosis.
• Serologic testing, employing a two-step process, supports the diagnosis.
• Treatment strategies are stage-dependent, utilizing antibiotics like doxycycline, amoxicillin, and ceftriaxone.

Main Results:

• Lyme disease presents in three stages: early localized (erythema migrans), early disseminated (flu-like symptoms, neurological, cardiac), and late (arthritis).
• The validity of 'Chronic Lyme Disease' is questioned by experts, who caution against prolonged, unproven antimicrobial treatments.
• Co-infections such as Babesia, Ehrlichia, and Anaplasma can occur simultaneously due to shared tick vectors.

Conclusions:

• Lyme disease diagnosis requires careful clinical and serologic interpretation.
• Effective treatment depends on the stage of the disease.
• No preventative vaccine is currently available, emphasizing prevention through tick avoidance.